Simulated Portfolio · AI / Tech Focus · Aggressive-Balanced Mandate
THE OZ HOLE — TECH TRACKER
PORTFOLIO COMMAND · INITIATED MAY 25, 2026
CONNECTED · LOADING...
LAST UPDATED:
MANDATE: AGGRESSIVE-BALANCED
SCOPE: AI / TECH → FULL LATITUDE
Total Capital
Deployed
0 positions
Cash Reserve
Total Return
vs. cost basis
Watchlist
5
names tracked
Next Deposit
$100 injection
CASH LEDGER
Cash Available
Total Injected
Deployed (cost)
% Deployed
DateTypeAmountBalance AfterNote
POSITIONS
0 OPEN
TickerSharesAvg CostCurrentMkt ValueReturnStatusNote
Select positions to close · 0 selected
WATCHLIST
5 NAMES
TickerTypeStatusPriceEntry ZoneM* FVLock-upThesis
Select names to remove · 0 selected
DECISION LOG
2 ENTRIES
CBRS — Cerebras Systems
WATCHING
MAY 25, 2026
At $253.50, CBRS is trading at a 341% premium to Morningstar's fair value of $188.94. Bull case is real — 76% YoY revenue growth, $20B OpenAI deal, AWS Bedrock integration, 47% net margin. But 86% UAE revenue concentration and 104x P/S ratio mean we are paying for a story, not a valuation. Lock-up expires November 14, 2026. Target entry zone: $195–$215 post-lockup or on a significant catalyst dip.
Missing further upside if CBRS climbs from $253. Accepted — paying 341% above fair value at this portfolio size is negative EV.
Enter a fractional position ($1–2). Rejected — too small to matter, creates psychological attachment without meaningful upside.
PORTFOLIO — Day 1
HOLD CASH
MAY 25, 2026
Holding full $100 in cash. No IPOs currently priced for retail entry at a compelling valuation. CBRS just listed — needs post-lockup observation. Pre-IPO names not yet accessible. Patience is a position.
Opportunity cost of missing CBRS Day 1 pop (+68%). Accepted — negative EV on 20x oversubscribed IPO opens historically.
N/A — no viable alternative deployment targets at this time.
RULES OF ENGAGEMENT
7 STANDING ORDERS
01
Cash deployment is the manager's call. Every hold and every deploy comes with a written thesis before the position is taken — no action without a documented reason.
02
No Day 1 IPO buys. Minimum 30-day observation window on any new listing unless thesis conditions are exceptional and documented.
03
Position sizing: no single position exceeds 40% of total capital. Protects against a single bad call wiping the portfolio.
04
Every decision includes a documented alternative — what was considered and rejected, and the specific reason why.
05
Post-mortems are mandatory on any position that moves ±15% or more. Learning happens at the extremes — review both wins and losses.
06
Monthly $100 injection on the 5th. Whether and when to deploy it is part of the exercise — holding is a decision too.
07
Full asset-class latitude expands as the thesis library grows. Earn it position by position. AI/Tech first, then broader exposure.
Rules exist to prevent emotional decisions, not good ones. They can be updated with documented rationale.